These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 1294124)
41. Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infections. Helfand MS; Bonomo RA Clin Infect Dis; 2006 Dec; 43(11):1415-6. PubMed ID: 17083013 [No Abstract] [Full Text] [Related]
42. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517 [TBL] [Abstract][Full Text] [Related]
43. [Antibiotics in the treatment scheme of peritonitis of appendicular origin]. Sherlanov AP Antibiotiki; 1972 Dec; 17(12):1098-103. PubMed ID: 4348898 [No Abstract] [Full Text] [Related]
44. Laparoscopic pneumoperitoneum in acute peritonitis does not increase bacteremia or aggravate metabolic or hemodynamic disturbances. Collet e Silva FD; Ramos RC; Zantut LF; Poggetti RS; Fontes B; Birolini D Surg Laparosc Endosc Percutan Tech; 2000 Oct; 10(5):305-10. PubMed ID: 11083214 [TBL] [Abstract][Full Text] [Related]
45. Neutrophil dynamics in abdominal cavity of peritonitic rats treated with antiseptics. Celdrán A; Iñarrea P; Fernández J; Larrocha C; Madero R Int Surg; 1993; 78(4):354-6. PubMed ID: 8175268 [TBL] [Abstract][Full Text] [Related]
46. Immunotherapeutic modification by Tinospora cordifolia of abdominal sepsis induced by caecal ligation in rats. Dahanukar SA; Thatte UM; Pai N; More PB; Karandikar SM Indian J Gastroenterol; 1988 Jan; 7(1):21-3. PubMed ID: 3338823 [No Abstract] [Full Text] [Related]
47. Heparin treatment of live Escherichia coli bacteremia in rats. Horwitz DL; Ballantine TV; Coran AG; Herman CM J Surg Res; 1972 Sep; 13(3):120-5. PubMed ID: 4563151 [No Abstract] [Full Text] [Related]
48. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia. Thatte UM; Kulkarni MR; Dahanukar SA J Postgrad Med; 1992; 38(1):13-5. PubMed ID: 1512717 [TBL] [Abstract][Full Text] [Related]
49. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Tan XX; Actor JK; Chen Y Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926 [TBL] [Abstract][Full Text] [Related]
50. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis. Tsukada K; Katoh H; Shiojima M; Takenoshita S; Nagamachi Y APMIS; 1993 Feb; 101(2):97-100. PubMed ID: 8489768 [TBL] [Abstract][Full Text] [Related]
51. Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria. Kung AH; Ammons WS; Lin Y; Kohn FR Prog Clin Biol Res; 1994; 388():255-63. PubMed ID: 7831363 [No Abstract] [Full Text] [Related]
52. Validation of therapeutic claims of Tinospora cordifolia: a review. Panchabhai TS; Kulkarni UP; Rege NN Phytother Res; 2008 Apr; 22(4):425-41. PubMed ID: 18167043 [TBL] [Abstract][Full Text] [Related]
53. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by tinospora cordifolia. Mathur SK J Postgrad Med; 1992; 38(2):102. PubMed ID: 1294124 [No Abstract] [Full Text] [Related]